New surgical method on bladder tumours at the „Wiener Privatklinik“

Bladder tumours are the eleventh most common tumours world-wide and with an incidence of 8.9 out of 100.000 men and 2.2 out of 100.000 women respectively they prove to be gender-linked considerably still. Numbers of 2008 see Spain on top in Europe with 41.5 men out of 100.000 being affected. In 2012 a total of 1496 people were treated in Austria with 1092 men and 404 women being afflicted. Both numbers of new cases and mortality were highest in Vienna. (Source: Statistik Austria) 

50% of all bladder tumours are directly linked to smoking as the most decisive risk factor. As aromatic amines and polycyclic aromatic hydrocarbons are being excreted by the kidneys, these substances stay in the bladder for a considerable period of time, which allows them to develop their carcinogenic effect there.

As for symptoms visible but painless hematuria is most common here. Do see a urologist quickly if this occurs with you personally. The urine will be checked in this case, followed by an ultrasonography both of the bladder and the kidneys and a cystoscopy.  Most of the patients need not dread these two procedures as endoscopic instruments have come to be particularly thin and flexible so that both of them can be carried out problem-free under local anaesthesia. 
It goes without saying that this service is offered in my surgery.
In case these three checks should confirm a suspected bladder tumour surgery has to follow.

I can offer an entirely new surgical method called fluorescence cystoscopy in the “Wiener Privatklinik” in that a liquid (hexamino laevuline acid) is applied in the bladder via a urinary catheter approximately an hour prior to the operation itself.
This operational method makes it possible to surgically remove a much higher percentage of tumours than by the standard one. (92% against 71%)
The aggressive “Carcinoma in situ/CIS”, a particularly insidious form of a bladder tumour, is even more successfully removed (98% against 65%)
Into the bargain, this method reduces follow-up intervention  dramatically  (below 10% within 12 months against 50% within 12 months), which has been proved in a number of relevant studies.